Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia (FRAME)
Flexibility, Resistance, Aerobic, Movement Execution (FRAME) Training Program to Improve Gait Capacity in Adults With Hereditary Spastic Paraplegia: Protocol for a Single-cohort Feasibility Trial
Hereditary Spastic Paraplegia (HSP) is a group of inherited neurological disorders that cause progressive weakness and stiffness (spasticity) in the legs, reducing balance and walking ability. At present, there are no structured rehabilitation programs specifically designed to improve walking in people with HSP.
This study aims to find out whether a structured, therapist-guided exercise program called FRAME training can be delivered successfully to people with HSP, and whether it may help improve their walking. The program combines flexibility, muscle strengthening, motor control, balance and aerobic exercises. At the end of the program, participants receive a written manual and video tutorials to help them keep exercising at home.
研究概览
详细说明
Hereditary Spastic Paraplegia (HSP) is a heterogeneous group of inherited neurological disorders. It is characterized by progressive lower-limb weakness and spasticity that significantly impair walking endurance and speed. Several interventions have been studied for specific impairments, but there are still no comprehensive, structured neurorehabilitation programs designed to improve walking function in this population. This study explores a composite training approach (FRAME) that addresses the main factors limiting gait in HSP: reduced flexibility, muscle weakness, impaired motor control and balance, and low aerobic capacity.
Participants attend 10 to 16 therapist-guided sessions of 60 to 120 minutes, once or twice a week according to individual preferences and capabilities. Each session may include four components:
- Flexibility: stretching of the muscles typically affected by spasticity (triceps surae, adductors, rectus femoris, hamstrings), combined with biphasic high-frequency sensory electrical stimulation (100 Hz, 200 µs, intensity just below motor threshold, 30 minutes) to reduce muscle tone and enhance mobility.
- Resistance training and balance: strengthening of the muscles typically weakened in HSP, especially the proximal hip and trunk muscles. Core stability and resistance exercises are performed in sitting or standing under mild instability to promote muscle activation, balance and coordination.
- Movement execution and balance: gait training based on motor learning principles (repetitive task-oriented practice, variable practice, graded practice), with standing balance challenges and varied walking tasks (fast, slow, sideways and backward walking, stair climbing).
- Aerobic training: high-intensity interval training (HIIT), which has been shown to produce greater cardiovascular benefits than moderate-intensity exercise at a lower perceived effort. HIIT includes a 5-minute warm-up, two sets of 10 intervals (30 seconds high intensity / 30 seconds passive rest) with 5 minutes of rest between sets, and a 5-minute cool-down. The exercise mode (walking, running, cycling or squatting) is chosen to suit each participant.
At the end of the program, participants receive a transfer package (written manual and video tutorials) to support long-term home exercise.
This study is expected to give clinicians insight into whether a comprehensive, clinically oriented program can be delivered to adults with HSP and how much it may help them walk better. It will also inform future translational research in this field.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Lombardy
-
Bosisio Parini、Lombardy、意大利、23842
- Scientific Institute, IRCCS E. Medea, Department of Bosisio Parini, Lecco, Italy.
-
-
Veneto
-
Pieve di Soligo、Veneto、意大利、31053
- Scientific Institute, IRCCS E. Medea, Department of Pieve di Soligo, Treviso, Italy
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Adults diagnosed with Hereditary Spastic Paraplegia.
- Presence of any functional deficit in the lower limbs that affects walking, such as muscle weakness, hypertonia, or balance issues.
- Ability to walk without the need for physical contact with another person, as defined by a Functional Ambulation Category score of 3 or higher.
- Ability to understand simple instructions, comprehend the purpose of the study, willingness to participate and undergo at least 10 treatment sessions, eligible and willing to sign the informed consent.
Exclusion Criteria:
- Botulinum toxin or surgery to treat lower limb hypertonia in the six months prior to enrollment in the study.
- Contraindications for moderate physical activity, such as stretching exercises, muscle strength training, and aerobic capacity training.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:HSP Cohort
The whole cohort of HSP patients will receive the same comprehensive neurorehabilitation program aiming at improving gait capabilities (speed and endurance). The content and the dose of the treatment will be personalized according to patient's specific needs and preferences. |
Flexibility: static and dynamic stretching combined with sensory, high-frequency electrical stimulation to reduce spasticity and improve mobility. Resistance training: core stability and lower limb strength training in conditions of instability, to improve strength, coordination, and balance. Movement execution training: gait training according to motor learning principles. Aerobic exercise: in the form of high-intensity interval training at the end of each session, to improve cardiovascular status and foster motor learning consolidation (probably due to the release of brain derived neurotrophic factors). |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Feasibility (recruitment rate).
大体时间:From study start up to 24 months.
|
Study feasibility in terms of achieving sufficient recruitment rate, defined as the enrollment of 20 patients within 24 months from the start of the study. |
From study start up to 24 months.
|
|
Feasibility (adherence rate).
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1).
|
Study feasibility in terms of achieving adequate adherence to the treatment plan, defined as completing at least 75% of the scheduled treatment sessions, and in any case a minimum of 10 treatment sessions. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1).
|
|
Feasibility (retention rate).
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1).
|
Study feasibility in terms of achieving sufficient patient retention, defined as at least 75% of the enrolled patients completing the study with adequate adherence to the treatment. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1).
|
|
Feasibility (safety).
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1).
|
Study feasibility in terms of absence of any serious adverse event related to patient participation in the study. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1).
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Six Minute Walking Test (6MWT).
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
The 6MWT is a clinical assessment of gait endurance, by measuring the distance covered (metres) while walking on a straight even path (30 meters) for six minutes. According to original instructions, the patient is asked to walk along the path as fast as possible, taking turns at the edges of the path. Patients are allowed to walk autonomously or with assistive devices and to rest by standing. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
|
Ten Metre Walk Test (10MWT).
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
The 10MWT is used to assess walking speed in meters/second (m/s) over a short distance. The total time taken to walk six meters (the central portion of a 10-meter walkway) is recorded to the nearest hundredth of a second. 6 meters is then divided by the total time taken to ambulate and recorded in m/s. Two trials at comfortable pace are performed, followed by two trials at fast pace. Averages (one for comfortable pace, one for fast pace) are recorded. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
其他结果措施
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Passive range of motion.
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
An inclinometer will be used to measure the passive range of motion for ankle dorsiflexion, knee flexion, hip abduction, and hip extension, on both sides. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
|
Hereditary Spastic Paraplegia - Self Notion and Perception Questionnaire (HSP-SNAP).
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
HSP-SNAP is a questionnaire used to assess the self-perception of individuals diagnosed with hereditary spastic paraplegia (HSP). HSP-SNAP includes 12 questions, with 2 items dedicated to each symptom dimension (stiffness, weakness, imbalance, reduced endurance, fatigue, and pain). Each pair of items for a given dimension includes both positive and negative responses to prevent automatic answers. The HSP-SNAP employs a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). To account for both positive and negative items, scoring is as follows: for items with a positive tone, the score is calculated as "patient's score minus 1" (pt score-1); for negative items, the score is "5 minus the patient's score" (5-pt score). The overall score is the sum of all item scores, ranging from 0 to 48. A higher score indicates better well-being and milder symptoms. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
|
Functional Reach Test (FRT).
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
FRT evaluates dynamic balance while standing. Patient is asked to stand with one shoulder flexed at 90 degrees and the hand making a fist, and then to bend forward up to the limit of balance, right before taking a step to prevent falling. A horizontal ruler taped on the wall is used to measure the difference in position of the head of the third metacarpal bone from starting to end position. Patients are not allowed to touch the wall or rotate the trunk while bending forward. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
|
Five times Sit-to-Stand (5TSTS).
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
The 5TSTS test is an assessment to evaluate lower body strength, balance, and functional mobility. The test involves the participant sitting in a chair, then standing up and sitting down five times as quickly as possible, without using their arms for assistance. The time taken to complete the five repetitions is recorded. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
|
modified Spastic Paraplegia Rating Scale (mSPRS)
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
The mSPRS is a clinical assessment tool used to evaluate the severity and progression of symptoms in individuals with hereditary spastic paraplegia. The scale measures aspects such as spasticity, mobility, and functional abilities related to walking, balance, and limb function. The mSPRS has a scoring range from 0 to 28, with higher scores on the mSPRS indicating more severe symptoms and greater impairment in motor function and spasticity. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
|
Stabilometric platform.
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
With the patient standing over a stabilometric platform, two kinematic assessments will be performed: (1) static stance, by standing for 30 seconds with eyes open and 30 seconds with eyes closed; (2) limits of stability, by bending with the body in different direction, displacing the centre of mass towards anterior, posterior, and lateral targets projected on a screen in front of the patient. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
|
Isometric strength.
大体时间:Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
A dynamometer will be used to measure isometric strength for ankle dorsiflexors, ankle plantarflexors, knee extensors, knee flexors, hip extensors, hip flexors, hip abductors, on both sides. |
Enrolment (T0), end of treatment five to ten weeks after T0 (T1), follow-up 12 weeks after T1 (T2).
|
合作者和调查者
调查人员
- 首席研究员:Leonardo Boccuni, PhD、Scientific Institute, IRCCS E. Medea, Department of Conegliano, Treviso, Italy.
出版物和有用的链接
一般刊物
- Eng JJ, Tang PF. Gait training strategies to optimize walking ability in people with stroke: a synthesis of the evidence. Expert Rev Neurother. 2007 Oct;7(10):1417-36. doi: 10.1586/14737175.7.10.1417.
- Bellofatto M, De Michele G, Iovino A, Filla A, Santorelli FM. Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature. Front Neurol. 2019 Jan 22;10:3. doi: 10.3389/fneur.2019.00003. eCollection 2019.
- Crozier J, Roig M, Eng JJ, MacKay-Lyons M, Fung J, Ploughman M, Bailey DM, Sweet SN, Giacomantonio N, Thiel A, Trivino M, Tang A. High-Intensity Interval Training After Stroke: An Opportunity to Promote Functional Recovery, Cardiovascular Health, and Neuroplasticity. Neurorehabil Neural Repair. 2018 Jun;32(6-7):543-556. doi: 10.1177/1545968318766663. Epub 2018 Apr 20.
- Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42(3):174-83. doi: 10.1159/000358801. Epub 2014 Mar 5.
- Thijs L, Voets E, Denissen S, Mehrholz J, Elsner B, Lemmens R, Verheyden GS. Trunk training following stroke. Cochrane Database Syst Rev. 2023 Mar 2;3(3):CD013712. doi: 10.1002/14651858.CD013712.pub2.
- Maccora S, Torrente A, Di Stefano V, Lupica A, Iacono S, Pilati L, Pignolo A, Brighina F. Non-pharmacological treatment of hereditary spastic paraplegia: a systematic review. Neurol Sci. 2024 Mar;45(3):963-976. doi: 10.1007/s10072-023-07200-1. Epub 2023 Nov 16. No abstract available.
- Boccuni L, Bortolini M, Stefan C, Dal Molin V, Dalla Valle G, Martinuzzi A. Flexibility, Resistance, Aerobic, Movement Execution (FRAME) training program to improve gait capacity in adults with Hereditary Spastic Paraplegia: protocol for a single-cohort feasibility trial. Front Neurol. 2025 Feb 18;16:1441512. doi: 10.3389/fneur.2025.1441512. eCollection 2025.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 1130
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Anonymized individual participant data will be shared with other researchers upon reasonable request.
IPD 共享时间框架
Start Date: June 2027. End Date: June 2037.
IPD 共享访问标准
Any researcher accredited by non-profit clinical and research centre.
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
- 分析代码
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.